Twist Biopharma GPCR Library

Unlock the discovery of antibodies to this difficult target class

GPCRs are hard to drug. However, Twist produces synthetic mAb libraries for focus on effective sequence space and simultaneous screening against multiple targets. Twist Biopharma can develop over 100,000 different GPCR binding motifs to generate new leads against any GPCR of interest.

Genes

Oligo Pools

NGS Target Enrichment Solutions

Variant Libraries

Synthetic Controls

Antibody Discovery

Twist Biopharma GPCR Library

Related Resources

Developing Therapeutics Against Virtually Any Target with New Antibody Libraries (Mandarin)

Precision Synthesis of Variant Libraries Enables Comprehensive Interrogation of Single-Site